- Home
- PMCB vs BON Comparison
PMCB vs BON Comparison
Compare PMCB & BON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMCB
- BON
- Stock Information
- Founded
- PMCB 1996
- BON 2006
- Country
- PMCB United States
- BON China
- Employees
- PMCB N/A
- BON N/A
- Industry
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- BON Medicinal Chemicals and Botanical Products
- Sector
- PMCB Health Care
- BON Health Care
- Exchange
- PMCB Nasdaq
- BON Nasdaq
- Market Cap
- PMCB 7.3M
- BON 5.9M
- IPO Year
- PMCB N/A
- BON 2021
- Fundamental
- Price
- PMCB $1.03
- BON $1.41
- Analyst Decision
- PMCB
- BON
- Analyst Count
- PMCB 0
- BON 0
- Target Price
- PMCB N/A
- BON N/A
- AVG Volume (30 Days)
- PMCB 16.1K
- BON 1.2M
- Earning Date
- PMCB 09-16-2025
- BON 07-29-2025
- Dividend Yield
- PMCB N/A
- BON N/A
- EPS Growth
- PMCB N/A
- BON N/A
- EPS
- PMCB 1.29
- BON 4.17
- Revenue
- PMCB N/A
- BON $23,844,556.00
- Revenue This Year
- PMCB N/A
- BON $223.38
- Revenue Next Year
- PMCB N/A
- BON $18.82
- P/E Ratio
- PMCB $0.79
- BON $0.33
- Revenue Growth
- PMCB N/A
- BON N/A
- 52 Week Low
- PMCB $1.00
- BON $1.14
- 52 Week High
- PMCB $2.42
- BON $73.75
- Technical
- Relative Strength Index (RSI)
- PMCB 41.98
- BON 44.82
- Support Level
- PMCB $1.05
- BON $1.43
- Resistance Level
- PMCB $1.15
- BON $1.57
- Average True Range (ATR)
- PMCB 0.07
- BON 0.12
- MACD
- PMCB -0.01
- BON 0.03
- Stochastic Oscillator
- PMCB 20.00
- BON 52.50
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
About BON Bon Natural Life Limited
Bon Natural Life Ltd is engaged in the manufacturing of personal care ingredients, such as plants extracted fragrance compounds to perfume and fragrance manufacturers, natural health supplements such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements. Xi'an App-Chem is devoted to providing high quality and competitive prices and a stable supply of products and services for the functional food, personal care, natural medicine and other industries. It provides these products and services for third party customers, as well as for its own proprietary brands. The company has its geographic presence in PRC and in Overseas. The company derives maximum revenue from Bioactive food ingredients.